Department of Medicine, St Vincent's Medical School, University of Melbourne, Melbourne Academic Centre for Health, University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Central Clinical School, Alfred Hospital, Monash University, Melbourne VIC, Australia.
Semin Nucl Med. 2022 Nov;52(6):734-744. doi: 10.1053/j.semnuclmed.2022.04.007. Epub 2022 May 25.
The diagnosis, staging and therapeutic monitoring of lung cancer were amongst the first applications for which the utility of FDG PET was documented and FDG PET/CT is now a routine diagnostic tool for clinical decision-making. As well as having high sensitivity for detection of disease sites, which provides critical information about stage, the intensity of uptake provides deeper biological characterization, while the burden of disease also has potential clinical significance. These disease characteristics can easily be quantified on delayed whole-body imaging as the maximum standardized uptake value (SUV) and metabolic tumor volume (MTV), respectively. There have been significant efforts to harmonize the measurement of these features, particularly within the context of clinical trials. Nevertheless, however calculated, in general, a high SUV and large MTV have been shown to have an adverse prognostic significance. Nevertheless, the use of these parameters in the interpretation and reporting of clinical scans remains inconsistent and somewhat controversial. This review details the current status of semi-quantitative FDG PET/CT in the evaluation of lung cancer.
肺癌的诊断、分期和治疗监测是最早应用 FDG PET 进行评估的领域之一,目前 FDG PET/CT 已成为临床决策的常规诊断工具。FDG PET/CT 不仅对疾病部位的检测具有很高的敏感性,可提供有关分期的关键信息,其摄取强度还可提供更深层次的生物学特征,而疾病负担也具有潜在的临床意义。这些疾病特征可在延迟全身成像时轻松量化,分别为最大标准化摄取值(SUV)和代谢肿瘤体积(MTV)。人们已经做出了很大的努力来协调这些特征的测量,特别是在临床试验的背景下。然而,无论如何计算,一般来说,高 SUV 和大 MTV 都具有不良的预后意义。尽管如此,这些参数在临床扫描的解释和报告中的使用仍然不一致,并且存在一定争议。本综述详细介绍了 FDG PET/CT 在肺癌评估中的当前状况。